Log in

Relevant bibliographies by topics / Acute exacerbation of interstitial lung diseases

Contents

Journal articles

Academic literature on the topic 'Acute exacerbation of interstitial lung diseases'

Author: Grafiati

Published: 21 September 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Acute exacerbation of interstitial lung diseases.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Acute exacerbation of interstitial lung diseases"

1

Aritonang, Rachel S., Fanny Fachrucha, Mia Elhidsi, and Ginanjar Arum Desianti. "Oxygen Therapy in Exacerbation of Interstitial Lung Disease." Respiratory Science 4, no. 3 (2024): 221–31. http://dx.doi.org/10.36497/respirsci.v4i3.129.

Full text

Abstract:

Interstitial lung diseases (ILD) are a group of diseases that involve damage in the interstitial tissue, causing diffusion disorders which ultimately lead to hypoxemia. One of the conditions that aggravate hypoxemia in ILD patients is acute exacerbation. Acute exacerbation is a condition of deterioration of ILD that can occur in less than 1 month. During an acute exacerbation, there will be a worsening of the HRCT pattern with increased ground glass opacities and a worsening of the clinical picture including hypoxemia. Acute exacerbations are closely related to increased mortality rates. Oxyge

APA, Harvard, Vancouver, ISO, and other styles

2

Kolb, Martin, Benjamin Bondue, Alberto Pesci, et al. "Acute exacerbations of progressive-fibrosing interstitial lung diseases." European Respiratory Review 27, no. 150 (2018): 180071. http://dx.doi.org/10.1183/16000617.0071-2018.

Full text

Abstract:

Acute exacerbation of interstitial lung disease (ILD) is associated with a poor prognosis and high mortality. Numerous studies have documented acute exacerbation in idiopathic pulmonary fibrosis (IPF), but less is known about these events in other ILDs that may present a progressive-fibrosing phenotype. We propose defining acute exacerbation as an acute, clinically significant respiratory deterioration, typically less than 1 month in duration, together with computerised tomography imaging showing new bilateral glass opacity and/or consolidation superimposed on a background pattern consistent w

APA, Harvard, Vancouver, ISO, and other styles

3

Abo Elwafa, GihanS, NaglaaB Ahmed, AmanyA Abou Zeid, and MaiA Abo Elhasab. "Noninvasive ventilation in acute exacerbation of interstitial lung diseases." Egyptian Journal of Chest Diseases and Tuberculosis 72, no. 1 (2023): 99. http://dx.doi.org/10.4103/ecdt.ecdt_40_22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Drakopanagiotakis, Fotios, Philipp Markart, and Paschalis Steiropoulos. "Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers." International Journal of Molecular Sciences 24, no. 12 (2023): 10196. http://dx.doi.org/10.3390/ijms241210196.

Full text

Abstract:

Interstitial lung diseases (ILDs) are a large group of pulmonary disorders characterized histologically by the cardinal involvement of the pulmonary interstitium. The prototype of ILDs is idiopathic pulmonary fibrosis (IPF), an incurable disease characterized by progressive distortion and loss of normal lung architecture through unchecked collagen deposition. Acute exacerbations are dramatic events during the clinical course of ILDs, associated with high morbidity and mortality. Infections, microaspiration, and advanced lung disease might be involved in the pathogenesis of acute exacerbations.

APA, Harvard, Vancouver, ISO, and other styles

5

Drakopanagiotakis, Fotios, Ekaterina Krauss, Ira Michailidou, et al. "Lung Cancer and Interstitial Lung Diseases." Cancers 16, no. 16 (2024): 2837. http://dx.doi.org/10.3390/cancers16162837.

Full text

Abstract:

Lung cancer continues to be one of the leading causes of cancer-related death worldwide. There is evidence of a complex interplay between lung cancer and interstitial lung disease (ILD), affecting disease progression, management strategies, and patient outcomes. Both conditions develop as the result of common risk factors such as smoking, environmental exposures, and genetic predispositions. The presence of ILD poses diagnostic and therapeutic challenges in lung cancer management, including difficulties in interpreting radiological findings and increased susceptibility to treatment-related tox

APA, Harvard, Vancouver, ISO, and other styles

6

Matsunashi, Atsushi, Kazuma Nagata, Takeshi Morimoto, and Keisuke Tomii. "Mechanical ventilation for acute exacerbation of fibrosing interstitial lung diseases." Respiratory Investigation 61, no. 3 (2023): 306–13. http://dx.doi.org/10.1016/j.resinv.2023.01.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Papanikolaou, Ilias C., Fotios Drakopanagiotakis, and Vlasis S. Polychronopoulos. "Acute exacerbations of interstitial lung diseases." Current Opinion in Pulmonary Medicine 16, no. 5 (2010): 480–86. http://dx.doi.org/10.1097/mcp.0b013e32833ae49d.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Akulkina, L. A., M. Yu Brovko, A. A. Schepalina, et al. "A case of severe COVID-19 in a patient with progressive fibrosing interstitial lung disease." PULMONOLOGIYA 32, no. 5 (2022): 763–69. http://dx.doi.org/10.18093/0869-0189-2022-32-5-763-769.

Full text

Abstract:

Interstitial lung diseases (ILDs) is a wide group of diffuse parenchymal lung diseases that can lead to interstitial pulmonary fibrosis. Clinical course of all ILDs, in particular with chronic fibrosing phenotype, can be complicated by an acute exacerbation caused by infection. Today, data about clinical course of COVID-19 in patients with progressive interstitial lung diseases is limited. In this case we described the course of COVID-19 infection in a patient with an interstitial pneumonia with autoimmune features (IPAF) and a progressive pulmonary fibrosis (PPF). We also discussed the typica

APA, Harvard, Vancouver, ISO, and other styles

9

Magdy, Mohammed, Zainab Saaed, Emad Abd El-Aleem, and Madyan Mahmoud. "Clinical and radiological signs of acute exacerbation of interstitial lung diseases." Minia Journal of Medical Research 30, no. 3 (2019): 116–19. http://dx.doi.org/10.21608/mjmr.2022.221906.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Ito, Yoko, Gen Tazaki, Yusuke Kondo, Genki Takahashi, and Fumio Sakamaki. "Therapeutic effect of nintedanib on acute exacerbation of interstitial lung diseases." Respiratory Medicine Case Reports 26 (2019): 317–20. http://dx.doi.org/10.1016/j.rmcr.2019.02.021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!